2026-01-24 - Analysis Report
### Report for Salesforce (CRM) Stock Analysis

### Company Overview
Salesforce is a cloud-based software company that provides customer relationship management (CRM) solutions and other enterprise software products.

### Return Rate Comparison
- **Return Rate (Rate) of CRM:** 53.53%
- **Return Rate of VOO (Rate_vs):** 126.41%
- **Divergence:** -72.90, Relative Divergence: 1.70%

The return rate of CRM is significantly lower than that of the S&P 500. The current divergence of -72.90 and relative divergence of 1.70% indicate that the CRM stock is underperforming compared to the S&P 500.

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 59.0% | 23.1% | 47.0% | 1.4 | 130.4B |
| 2017-2019  | 53.0% | 23.1% | 28.0% | 1.4 | 154.8B |
| 2018-2020  | 58.0% | 34.9% | 34.0% | 1.1 | 211.8B |
| 2019-2021  | 42.0% | 34.9% | -23.0% | 1.1 | 241.9B |
| 2020-2022  | -74.0% | 53.6% | -81.0% | 1.2 | 126.2B |
| 2021-2023  | -4.0% | 53.6% | -24.0% | 1.4 | 250.5B |
| 2022-2024  | 48.0% | 39.3% | 18.0% | 1.4 | 318.3B |
| 2023-2025  | 49.0% | 35.1% | -26.0% | 1.2 | 252.2B |

The alpha values indicate that the stock has generated returns in excess of the S&P 500 in some years, but not consistently. The beta values are generally high, indicating a high level of volatility.

### Recent Stock Price Fluctuations
- **Close:** $228.05
- **Last-market:** $228.05 (change of -0.02)
- **5-day SMA:** $224.98
- **20-day SMA:** $249.31
- **60-day SMA:** $248.01

The stock price has shown a downward trend over the past few days, with the 5-day SMA indicating a downward momentum.

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return
- **Market Risk Indicator (MRI):** 0.70 (Medium Investment)
- **RSI:** 30.81
- **PPO:** -1.54
- **Hybrid Signal:** Buy
- **Risk Level:** Medium (MRI 0.70)
- **Recent (20 days) relative divergence change:** 1.60 (+) improving
- **7-day Rank change:** 200 (+) rank up
- **7-day Dynamic Expected Return change:** 5185.70 (+) improving
- **Expected Return (%):** 198.50%

The RSI and PPO indicators suggest that the stock is oversold, with the RSI indicating 30.81 and the PPO indicating -1.54. The hybrid signal is buy, and the risk level is medium. The recent relative divergence change and rank change are improving.

### Recent News & Significant Events
- **2026-01-21:** What Is Spooking CRM Stock Investors? - Forbes
- **2026-01-23:** Strong Cash Yield: Is Salesforce Stock A Buy? - Trefis
- **2026-01-02:** Salesforce (CRM) Stock Trades Down, Here Is Why - Yahoo Finance
- **2026-01-23:** Salesforce (NYSE:CRM) Valuation Check As Agentforce AI Push Meets Share Price And Growth Skepticism - simplywall.st
- **2026-01-23:** After a 32% Reckoning In Shares, Investors Are Calling The Salesforce Bottom. It's Time To Rally | CRM - 24/7 Wall St.

The recent news and significant events suggest that the stock is experiencing a downward trend, with investors expressing concerns about the stock's valuation and growth.

### Analyst Opinions
- **Analyst Consensus:**
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.64 (~Buy)
  - Opinions: 53
  - Target Price (avg/high/low): 329.65 / 475.00 / 223.00

The analyst consensus is buy, with a mean rating of 1.64 (~Buy) and 53 opinions.

### Recent Earnings Analysis
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-12-04 | 2.2 | 10.26 B$ |
| 2025-09-04 | 1.97 | 10.24 B$ |
| 2025-05-29 | 1.61 | 9.83 B$ |
| 2024-12-04 | 1.6 | 9.44 B$ |
| 2025-12-04 | 1.6 | 9.44 B$ |

The recent earnings analysis indicates a decline in earnings per share (EPS) and revenue in the past quarter.

### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-10-31 | $10.26B | 78.02% |
| 2025-07-31 | $10.24B | 78.10% |
| 2025-04-30 | $9.83B | 76.96% |
| 2025-01-31 | $9.99B | 77.81% |
| 2024-10-31 | $9.44B | 77.71% |

The revenue and profitability analysis indicates a decline in profit margin in the past quarter.

### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-10-31 | $60.02B | 3.48% |
| 2025-07-31 | $61.33B | 3.08% |
| 2025-04-30 | $60.67B | 2.54% |
| 2025-01-31 | $61.17B | 2.79% |
| 2024-10-31 | $58.52B | 2.61% |

The capital and profitability analysis indicates a decline in return on equity (ROE) in the past quarter.

### Comprehensive Analysis (Summary of Previous Items)

Based on the analysis, the CRM stock is experiencing a downward trend, with a decline in earnings per share (EPS) and revenue, as well as a decrease in profit margin and return on equity (ROE). However, the analyst consensus is buy, and the hybrid signal is buy, with a medium risk level. The recent relative divergence change and rank change are improving, and the expected return is high.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.